Valtech Cardio Treats First Mitral Regurgitation Patients with Percutaneous Annuloplasty Device Without Open-Heart Surgery (via PR Newswire)Download image OR YEHUDA, Israel, May 16, 2013 /PRNewswire/ — Valtech Cardio Ltd., a medical device company that develops solutions for mitral valve repair and replacement, announced today that two patients diagnosed with severe mitral regurgitation (MR) have been treated successfully with the Transfemoral…
published: May 17, 2013 in: Cardio, Techniques